Exemed Pharma Gets CDSCO Panel Nod To Study FDC of Montelukast, Bilastine Dr. Divya Colin21 July 2023 10:28 AM GMTNew Delhi: Exemed Pharmaceuticals has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Allergic Rhinitis-Phenotypes, Challenges, Therapeutic Approach and Role of Montelukast Fexofenadine Combination Dr. Kamal Kant Kohli30 Jun 2023 6:15 AM GMTAtopic diseases are becoming increasingly prevalent worldwide, and allergic rhinitis (AR), an IgE-mediated inflammatory disease, is one among them....
NPPA Fixes Retail Price Of 25 Formulations, Details Susmita Roy28 March 2023 12:30 PM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, the Government of...
Decoding Complications of Allergic Rhinitis and Role of Early Interventions Dr. Kamal Kant Kohli22 Feb 2023 6:15 AM GMTAllergic Rhinitis (AR) is a symptomatic inflammatory disorder of the nasal membranes triggered by exposure to allergens. It is clinically presented by...
NPPA fixes ceiling price of 12 Scheduled Formulations, Details Susmita Roy26 Dec 2022 12:30 PM GMTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling prices for 12 scheduled formulations...
83 Drug Samples Fail To Qualify CDSCO Test Susmita Roy14 Dec 2022 12:30 PM GMTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 83 medicine...
50 Drug Samples Fail To Qualify CDSCO Test Susmita Roy17 Nov 2022 11:54 AM GMTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 50 medicine...
Synokem Pharma Gets CDSCO Panel nod to study Anti Allergic Combination Drug Dr. Divya Colin15 Oct 2022 12:30 PM GMTNew Delhi: Synokem Pharmaceutical has got a go-ahead from the Subject Expert Committee (SEC) functional under Central Drug Standard Control...
Allergic Rhinitis-Management Strategies and Review of Recent Indian Guidelines Dr. Kamal Kant Kohli10 Oct 2022 7:15 AM GMTAllergic Rhinitis is widely recognized as the most common allergic disease, is an allergen-induced upper-airway inflammatory disease characterized by...
Respiratory Allergies in India and Clinical Review of Montelukast Fexofenadine Combination in its Management Dr. Kamal Kant Kohli24 Sep 2022 6:27 AM GMTAllergic respiratory diseases (ARDs) are caused by the production of IgE antibodies to airborne allergens, causing various clinical manifestations in...
Infographic: Allergic Rhinitis-Quick Overview of Treatment Algorithm Dr. Kamal Kant Kohli11 July 2022 7:15 AM GMT.single-featured{display:none;}Allergic rhinitis (AR), an inflammatory illness of the upper respiratory tract, is now being acknowledged as a global...
Managing co-existing allergic rhinitis and asthma: Analyzing the role of Montelukast-levocetirizine combination Dr. Kamal Kant Kohli13 Jun 2022 7:11 AM GMTAllergic rhinitis (AR) is now being acknowledged as a global health burden with estimates highlighting that 10%-25% of the population worldwide is...
